Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis
NCT ID: NCT05462470
Last Updated: 2022-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
255 participants
OBSERVATIONAL
2008-01-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anatomical Resection in Colorectal Liver Metastases Patients
NCT05673564
Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
NCT06934018
Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.
NCT05273489
Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
NCT00172159
Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter Trial
NCT05268549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
repeat liver surgery
repeat liver surgery for liver relapse lesions
Repeat Liver Surgery
repeat liver surgery included not only hepatectomy, but also ablative treatment, including radiofrequency ablation (RFA) and microwave ablation (MWA)
non-repeat liver surgery
non-repeat liver surgery, just only systemic palliative chemotherapy
Non-Repeat Liver Surgery
Systemic palliative chemotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repeat Liver Surgery
repeat liver surgery included not only hepatectomy, but also ablative treatment, including radiofrequency ablation (RFA) and microwave ablation (MWA)
Non-Repeat Liver Surgery
Systemic palliative chemotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* received conversion therapy
* underwent conversion hepatectomy
Exclusion Criteria
* uncontrollable extrahepatic metastases, such as peritoneal, bone, brain metastasis
* history of previous hepatectomy
* the primary tumor was not resected or palliative resection
* R1 or R2 liver resection
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xu jianmin
Deputy director of the department of general surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianmin Xu, MD
Role: PRINCIPAL_INVESTIGATOR
Department of General Surgery, Zhongshan Hospital, Fudan University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IU-CRLM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.